Showing results (151-160 of 193) with videos related to
Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|April 12, 2011
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferonAdrian M Di Bisceglie, Anne M Stoddard, Jules L Dienstag, et al.Hepatology (Baltimore, Md.)|February 24, 2005
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis CAlan Lee Rothman, Chihiro Morishima, Herbert L Bonkovsky, et al.Gastroenterology|November 15, 2006
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis CHerbert L Bonkovsky, Deepa Naishadham, Richard W Lambrecht, et al.Hepatology (Baltimore, Md.)|June 22, 2010
Outcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R Morgan, Marc G Ghany, Hae-Young Kim, et al.The American Journal of Gastroenterology|October 29, 2019
Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level ViremiaKali Zhou, Abdus S Wahed, Stewart Cooper, et al.The New England Journal of Medicine|April 9, 2010
Telaprevir for previously treated chronic HCV infectionJohn G McHutchison, Michael P Manns, Andrew J Muir, et al.Journal of Hepatocellular Carcinoma|February 9, 2024
Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United StatesFernand Bteich, Kush Desai, Chenxin Zhang, et al.Gastroenterology|September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis CMarc G Ghany, Anna S F Lok, James E Everhart, et al.Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 2, 2021
Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP studyMarina Serper, Donna M Evon, Jipcy Amador, et al.Pageof 20